Achaogen (AKAO) Stock: Falling On Mixed FDA Response

Achaogen Inc (NASDAQ: AKAO) is havinga¬† rough start to the trading session this morning, and for good reason. The company released news from the FDA surrounding its New Drug Application that led to mixed results from the regulatory agency. Of course, mixed results concerned invesotrs, leading to declines in the value of the stock. Today, … Read more